Bio-Rad Laboratories, Inc. (BIO)
386.12
-1.58
(-0.41%)
USD |
NYSE |
Aug 31, 16:00
386.18
+0.06
(+0.02%)
Pre-Market: 20:00
Bio-Rad Laboratories Cash from Operations (TTM) : 492.60M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 492.60M |
| March 31, 2026 | 510.40M |
| December 31, 2025 | 532.20M |
| September 30, 2025 | 491.47M |
| June 30, 2025 | 534.18M |
| March 31, 2025 | 515.32M |
| December 31, 2024 | 454.60M |
| September 30, 2024 | 411.48M |
| June 30, 2024 | -46.05M |
| March 31, 2024 | 332.16M |
| December 31, 2023 | 374.94M |
| September 30, 2023 | 1.615B |
| June 30, 2023 | 558.92M |
| March 31, 2023 | 469.76M |
| December 31, 2022 | 1.436B |
| September 30, 2022 | -799.24M |
| June 30, 2022 | 781.27M |
| March 31, 2022 | 549.21M |
| December 31, 2021 | -415.44M |
| September 30, 2021 | 1.573B |
| June 30, 2021 | 1.126B |
| March 31, 2021 | 797.93M |
| December 31, 2020 | 575.33M |
| September 30, 2020 | -339.70M |
| June 30, 2020 | -22.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 305.96M |
| December 31, 2019 | 457.90M |
| September 30, 2019 | 403.10M |
| June 30, 2019 | 365.63M |
| March 31, 2019 | 288.09M |
| December 31, 2018 | 285.49M |
| September 30, 2018 | 249.85M |
| June 30, 2018 | 216.05M |
| March 31, 2018 | 200.69M |
| December 31, 2017 | 104.14M |
| September 30, 2017 | 129.89M |
| June 30, 2017 | 153.02M |
| March 31, 2017 | 167.68M |
| December 31, 2016 | 216.43M |
| September 30, 2016 | 157.27M |
| June 30, 2016 | 187.94M |
| March 31, 2016 | 149.32M |
| December 31, 2015 | 186.21M |
| September 30, 2015 | 191.00M |
| June 30, 2015 | 191.47M |
| March 31, 2015 | 233.84M |
| December 31, 2014 | 273.31M |
| September 30, 2014 | 306.01M |
| June 30, 2014 | 286.11M |
| March 31, 2014 | 223.90M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Thermo Fisher Scientific, Inc. | 9.013B |
| Agilent Technologies, Inc. | 1.609B |
| Danaher Corp. | 6.635B |
| Illumina, Inc. | 1.095B |
| Revvity, Inc. | 627.63M |